Ramsay Santé proposes Frédéric Collet as independent chairman

By Public Technologies
  • Ramsay Santé proposed former Novartis France President Frédéric Collet as independent chairman, subject to shareholder approval and completion of the planned distribution.
  • Proposed directors include former Crédit Agricole Group Chief Risk Officer Alexandra Boleslawski and Virginie Banet, founder of Iolite Financial Consulting.
  • Carrefour France CEO Alexandre de Palmas and former Swedish Prime Minister Fredrik Reinfeldt are also proposed as independent directors.
  • CEO Pascal Roché would join the board; five directors nominated by Ramsay Health Care would resign upon completion of the distribution.
  • Shareholders will vote on appointments December 4, 2026; the changes would take effect upon distribution, currently expected December 9.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ramsay Générale de Santé SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611160225OMX_____CNEWS_EN_GNW1001303550_en) on November 16, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.